title: Outcome of severe acute post-streptococcal glomerulonephritis in New Zealand children.
abstract: Post-streptococcal glomerulonephritis (PSGN) is the commonest cause of severe acute glomerulonephritis in New Zealand children, with the majority (85%) of the patients being of either Pacific Island or Maori ethnicity. We have performed a retrospective study on 27 pediatric patients with acute PSGN. Of these patients, those with crescentic glomerulonephritis (n = 11) had a greater tendency (72.7%) for needing acute dialysis and were left with persistent urinary sediment abnormalities after a mean follow-up of 3.2 years (95% confidence interval 2.1-4.3). The efficacy of immunosuppression in the group with crescentic disease was uncertain. The severity of renal histopathological abnormalities as judged by the total biopsy score did not correlate with either presentation or eventual outcome. Severe childhood acute post-streptococcal glomerulonephritis, although uncommon, results in significant long-term renal morbidity, particularly among Maori and Pacific Island children.
authors.affiliation: Department of Nephrology, Starship Children's Hospital, Auckland, New Zealand. wwong@adhb.govt.nz
authors.forename: William
authors.initials: W
authors.lastname: Wong
authors.forename: Maxwell Clarke
authors.initials: MC
authors.lastname: Morris
authors.forename: Jonathan
authors.initials: J
authors.lastname: Zwi
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D018450:Disease Progression; D005260:Female; D005922:Glomerulonephritis, IGA / Q000208:ethnology / Q000209:etiology / Q000473:pathology* / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007678:Kidney Glomerulus / Q000276:immunology / Q000473:pathology*; D008297:Male; D009520:New Zealand / Q000453:epidemiology; D006435:Renal Dialysis; D012189:Retrospective Studies; D013290:Streptococcal Infections / Q000150:complications / Q000208:ethnology / Q000473:pathology*; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents